211 related articles for article (PubMed ID: 356233)
21. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
22. The use of antilymphocyte globulin in renal allograft rejection. A controlled study.
Birkeland SA
Postgrad Med J; 1976; 52(5 Suppl):82-8. PubMed ID: 792853
[TBL] [Abstract][Full Text] [Related]
23. Cadaveric renal transplantation in patients over 55 years of age with special emphasis on immunosuppressive therapy.
Lundgren G; Fehrman I; Gunnarsson R; Lindholm B; Tillegård A; Ost L; Groth CG
Transplant Proc; 1982 Sep; 14(3):601-4. PubMed ID: 6758244
[No Abstract] [Full Text] [Related]
24. Enisoprost in renal transplantation. The Enisoprost Renal Transplant Study Group.
Adams MB
Transplantation; 1992 Feb; 53(2):338-45. PubMed ID: 1738927
[TBL] [Abstract][Full Text] [Related]
25. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
26. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
[TBL] [Abstract][Full Text] [Related]
27. Uses of antilymphocyte globulin in renal transplantation.
Novick AC
Urol Clin North Am; 1983 May; 10(2):253-62. PubMed ID: 6344386
[No Abstract] [Full Text] [Related]
28. Low-dose cyclosporine, anti-lymphocyte globulin, and steroids in first cadaveric renal transplantation.
Griño JM; Alsina J; Castelao AM; Sabate I; Mestre M; Gil-Vernet S; Andrés E; Sabater R
Transplant Proc; 1988 Oct; 20(5 Suppl 6):18-20. PubMed ID: 3051579
[No Abstract] [Full Text] [Related]
29. Comparison of Minnesota antilymphocyte globulin and OKT3 for induction of immunosuppression in renal transplant patients.
Light JA; Khawand N; Ali A; Brems W; Aquino A
Transplant Proc; 1989 Feb; 21(1 Pt 2):1738-40. PubMed ID: 2652569
[TBL] [Abstract][Full Text] [Related]
30. Treatment of multiple rejection episodes with ALG or ATGAM after cadaveric renal transplantation.
Toledo-Pereya LH; Whitten J; Baskin S; McNichol L; Thavarajah K; Lin W
Bol Asoc Med P R; 1984 Jul; 76(7):293-6. PubMed ID: 6383417
[No Abstract] [Full Text] [Related]
31. Improved results in high risk cadaveric kidney transplantation.
Toledo-Pereyra LH; Baskin S; McNichol L; Edford G; Whitten J; Allaben R
Proc Clin Dial Transplant Forum; 1980; 10():289-92. PubMed ID: 7050990
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppressive treatment of primary cadaveric renal transplant patients receiving kidneys from non-heart beating donors.
Ohshima S; Fujita T; Ono Y; Kinukawa T; Katoh N; Matsuura O
Artif Organs; 1996 Oct; 20(10):1130-6. PubMed ID: 8896734
[TBL] [Abstract][Full Text] [Related]
33. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function.
Matas AJ; Tellis VA; Quinn TA; Glicklich D; Soberman R; Veith FJ
Transplantation; 1988 Feb; 45(2):406-9. PubMed ID: 3278434
[TBL] [Abstract][Full Text] [Related]
34. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
35. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
36. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
[TBL] [Abstract][Full Text] [Related]
37. Medical research council trial of antilymphocyte globulin in renal transplantation. A multicenter randomized double-blind placebo controlled clinical investigation.
Bell PR; Blamey RW; Briggs JD; Castro JE; Hamilton DN; Knapp MS; Salaman JR; Sells RA; Williams G; Gowans JL; Peto R; Richards S; Phillips AW; Weinberg AL; Freestone DS
Transplantation; 1983 Jun; 35(6):539-45. PubMed ID: 6346595
[TBL] [Abstract][Full Text] [Related]
38. Immunosuppressive drugs used in clinical renal transplantation.
Chatterjee SN
Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101
[No Abstract] [Full Text] [Related]
39. [Use and limits of preventive antilymphocyte globulin therapy following kidney transplantation. A prospective randomized study].
Grundmann R; Wienand P; Meider G; Vlaho V; Pichlmaier H
Klin Wochenschr; 1984 Oct; 62(20):979-85. PubMed ID: 6389973
[TBL] [Abstract][Full Text] [Related]
40. Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study.
Novick AC; Hwei HH; Steinmuller D; Streem SB; Cunningham RJ; Steinhilber D; Goormastic M; Buszta C
Transplantation; 1986 Aug; 42(2):154-8. PubMed ID: 3526655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
